Bock O - Search Results

1

Brief psychotic disorder after abrupt withdrawal of hydroxyzine hydrochloride.

Bock O, Wenzel C, Herrmann J, Dillo W, Poehnert D, Bleich S, Frieling H. Bock O, et al. J Clin Psychopharmacol. 2014 Aug;34(4):526-7. doi: 10.1097/JCP.0000000000000145. J Clin Psychopharmacol. 2014. PMID: 24875068 No abstract available.

2

Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy.

Mengel M, Bock O, Priess M, Haller H, Kreipe H, Gwinner W. Mengel M, et al. Among authors: bock o. Clin Nephrol. 2008 Jun;69(6):408-16. doi: 10.5414/cnp69408. Clin Nephrol. 2008. PMID: 18538116

3

Compartment-specific quantitative gene expression analysis after laser microdissection from archival renal allograft biopsies.

Serinsöz E, Bock O, Kirsch T, Haller H, Lehmann U, Kreipe H, Mengel M. Serinsöz E, et al. Among authors: bock o. Clin Nephrol. 2005 Mar;63(3):193-201. doi: 10.5414/cnp63193. Clin Nephrol. 2005. PMID: 15786820

4

Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis.

Bock O, Muth M, Theophile K, Winter M, Hussein K, Büsche G, Kröger N, Kreipe H. Bock O, et al. Br J Haematol. 2009 Sep;146(5):510-20. doi: 10.1111/j.1365-2141.2009.07808.x. Epub 2009 Jul 13. Br J Haematol. 2009. PMID: 19604240 Free article.

5

Histological and molecular classification of chronic myeloproliferative disorders in the age of JAK2: persistence of old questions despite new answers.

Hussein K, Bock O, Kreipe H. Hussein K, et al. Among authors: bock o. Pathobiology. 2007;74(2):72-80. doi: 10.1159/000099120. Pathobiology. 2007. PMID: 17587878 Free article. Review.

6

Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.

Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H. Bock O, et al. J Pathol. 2005 Apr;205(5):548-57. doi: 10.1002/path.1744. J Pathol. 2005. PMID: 15726648

7

Myelofibrosis: molecular and cell biological aspects.

Kreipe H, Büsche G, Bock O, Hussein K. Kreipe H, et al. Among authors: bock o. Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S21. doi: 10.1186/1755-1536-5-S1-S21. eCollection 2012. Fibrogenesis Tissue Repair. 2012. PMID: 23259436 Free PMC article.

8

Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation.

Hussein K, Bock O, Seegers A, Flasshove M, Henneke F, Buesche G, Kreipe HH. Hussein K, et al. Among authors: bock o. Blood. 2007 May 1;109(9):4106-7. doi: 10.1182/blood-2006-12-061135. Blood. 2007. PMID: 17449802 Free article. No abstract available.

9

Different lineage involvement in myelodysplastic/myeloproliferative disease with combined MPLW515L and JAK2V617F mutation.

Hussein K, Theophile K, Buhr T, Beller A, Kreipe H, Bock O. Hussein K, et al. Among authors: bock o. Br J Haematol. 2009 Jun;145(5):673-5. doi: 10.1111/j.1365-2141.2009.07671.x. Epub 2009 Mar 31. Br J Haematol. 2009. PMID: 19344408 Free article. No abstract available.

10

Tubular chimerism occurs regularly in renal allografts and is not correlated to outcome.

Mengel M, Jonigk D, Marwedel M, Kleeberger W, Bredt M, Bock O, Lehmann U, Gwinner W, Haller H, Kreipe H. Mengel M, et al. Among authors: bock o. J Am Soc Nephrol. 2004 Apr;15(4):978-86. doi: 10.1097/01.asn.0000120369.92378.54. J Am Soc Nephrol. 2004. PMID: 15034100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

366 results

Search Page

Filters